Items | Phase I n (%) | Phase II n (%) | Phase III n (%) | Statistics | Effect size (η2 / V) | P-value |
---|---|---|---|---|---|---|
GAD-7 score | 6.77 ± 3.57 | 11.82 ± 3.56 a | 6.15 ± 2.87 c | F = 162.08 | η² = 0.37 | < 0.01** |
Level of anxiety |  |  |  | χ2  = 213.33 | V = 0.44 | < 0.01** |
None | 39 (20.7) | 1 (0.5) | 56 (29.8) | Â | Â | Â |
Mild | 126 (67.0) | 58 (30.9) | 111 (59.0) | Â | Â | Â |
Moderate | 8 (4.3) | 87 (46.3) | 17 (9.0) | Â | Â | Â |
Severe | 15 (8.0) | 42 (22.3) | 4 (2.1) | Â | Â | Â |
PHQ-9 score | 8.32 ± 4.30 | 14.20 ± 4.37 a | 8.77 ± 4.31 c | F = 107.56 | η² = 0.28 | < 0.01** |
Level of depression |  |  |  | χ2  = 193.71 | V = 0.52 | < 0.01** |
None | 16 (8.5) | 2 (1.1) | 21 (11.2) | Â | Â | Â |
Mild | 123 (65.4) | 23 (12.2) | 103 (54.8) | Â | Â | Â |
Moderate | 32 (17.0) | 77 (41.0) | 50 (26.6) | Â | Â | Â |
Moderately-severe | 9 (4.8) | 65 (34.6) | 6 (3.2) | Â | Â | Â |
Severe | 8 (4.3) | 21 (11.2) | 8 (4.3) | Â | Â | Â |